U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07950137) titled 'AI-ECG Screening for Early Heart Failure Diagnosis' on Nov. 15.

Brief Summary: The goal of this parallel-group cluster randomized clinical trial is to evaluate whether opportunistic screening for left ventricular systolic dysfunction (LVSD), using an artificial intelligence algorithm applied to electrocardiograms (AI-ECG), increases the detection of previously unrecognized LVSD among adults aged >=40 years receiving routine care in primary healthcare centers within the Brazilian Public Health System. LVSD is a key finding in the diagnosis of heart failure with reduced ejection fraction (HFrEF), a condition for which effective guidel...